Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 160

1.

Seroepidemiology of Burkholderia pseudomallei, Etiologic Agent of Melioidosis, in the Ouest and Sud-Est Departments of Haiti.

Weppelmann TA, Norris MH, von Fricken ME, Rahman Khan MS, Okech BA, Cannella AP, Schweizer HP, Sanford DC, Tuanyok A.

Am J Trop Med Hyg. 2018 Sep 17. doi: 10.4269/ajtmh.18-0352. [Epub ahead of print]

PMID:
30226137
2.

Lipid A remodeling is a patho-adaptive mechanism that impacts lipopolysaccharide recognition and intracellular survival of Burkholderia pseudomallei.

Norris MH, Somprasong N, Schweizer HP, Tuanyok A.

Infect Immun. 2018 Jul 23. pii: IAI.00360-18. doi: 10.1128/IAI.00360-18. [Epub ahead of print]

3.

Molecular determinants of Burkholderia pseudomallei BpeEF-OprC efflux pump expression.

Rhodes KA, Somprasong N, Podnecky NL, Mima T, Chirakul S, Schweizer HP.

Microbiology. 2018 Sep;164(9):1156-1167. doi: 10.1099/mic.0.000691. Epub 2018 Jul 19.

PMID:
30024368
4.

Transcriptional and post-transcriptional regulation of PenA β-lactamase in acquired Burkholderia pseudomallei β-lactam resistance.

Chirakul S, Norris MH, Pagdepanichkit S, Somprasong N, Randall LB, Shirley JF, Borlee BR, Lomovskaya O, Tuanyok A, Schweizer HP.

Sci Rep. 2018 Jul 13;8(1):10652. doi: 10.1038/s41598-018-28843-7.

5.

Outer Membrane Vesicle Vaccines from Biosafe Surrogates Prevent Acute Lethal Glanders in Mice.

Norris MH, Khan MSR, Chirakul S, Schweizer HP, Tuanyok A.

Vaccines (Basel). 2018 Jan 10;6(1). pii: E5. doi: 10.3390/vaccines6010005.

6.

Burkholderia pseudomallei natural competency and DNA catabolism: Identification and characterization of relevant genes from a constructed fosmid library.

Norris MH, Heacock-Kang Y, Zarzycki-Siek J, Bluhm AP, McMillan IA, Schweizer HP, Hoang TT.

PLoS One. 2017 Dec 18;12(12):e0189018. doi: 10.1371/journal.pone.0189018. eCollection 2017.

7.

Spatial transcriptomes within the Pseudomonas aeruginosa biofilm architecture.

Heacock-Kang Y, Sun Z, Zarzycki-Siek J, McMillan IA, Norris MH, Bluhm AP, Cabanas D, Fogen D, Vo H, Donachie SP, Borlee BR, Sibley CD, Lewenza S, Schurr MJ, Schweizer HP, Hoang TT.

Mol Microbiol. 2017 Dec;106(6):976-985. doi: 10.1111/mmi.13863. Epub 2017 Nov 17.

8.

Mechanisms of Resistance to Folate Pathway Inhibitors in Burkholderia pseudomallei: Deviation from the Norm.

Podnecky NL, Rhodes KA, Mima T, Drew HR, Chirakul S, Wuthiekanun V, Schupp JM, Sarovich DS, Currie BJ, Keim P, Schweizer HP.

MBio. 2017 Sep 5;8(5). pii: e01357-17. doi: 10.1128/mBio.01357-17.

9.

AOAC SMPR 2016.010.

Gee J, Arce J, Beck LC, Blank TR, Blyn L, Cahall R, Clark AJ, Currie B, Damer K, Davenport M, DeShazer D, Johns M, Keim PS, Kiss K, Lesho M, Lin N, Morse SA, Naraghi-Arani P, Ozanich R, Roberto F, Rozak D, Sahl J, Schaefer F, Schutzer S, Schweizer HP, Sozhamannan S, Tuanyok A, Coates S.

J AOAC Int. 2017 Jan 1;100(1):261-265. doi: 10.5740/jaoacint.SMPR2016.010. No abstract available.

PMID:
28825553
10.

Genome-scale analysis of the genes that contribute to Burkholderia pseudomallei biofilm formation identifies a crucial exopolysaccharide biosynthesis gene cluster.

Borlee GI, Plumley BA, Martin KH, Somprasong N, Mangalea MR, Islam MN, Burtnick MN, Brett PJ, Steinmetz I, AuCoin DP, Belisle JT, Crick DC, Schweizer HP, Borlee BR.

PLoS Negl Trop Dis. 2017 Jun 28;11(6):e0005689. doi: 10.1371/journal.pntd.0005689. eCollection 2017 Jun.

11.

An avirulent Burkholderia pseudomallei ∆purM strain with atypical type B LPS: expansion of the toolkit for biosafe studies of melioidosis.

Norris MH, Rahman Khan MS, Schweizer HP, Tuanyok A.

BMC Microbiol. 2017 Jun 7;17(1):132. doi: 10.1186/s12866-017-1040-4.

12.

Structural diversity of Burkholderia pseudomallei lipopolysaccharides affects innate immune signaling.

Norris MH, Schweizer HP, Tuanyok A.

PLoS Negl Trop Dis. 2017 Apr 28;11(4):e0005571. doi: 10.1371/journal.pntd.0005571. eCollection 2017 Apr.

13.

Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.

Bugrysheva JV, Sue D, Gee JE, Elrod MG, Hoffmaster AR, Randall LB, Chirakul S, Tuanyok A, Schweizer HP, Weigel LM.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00010-17. doi: 10.1128/AAC.00010-17. Print 2017 Jun.

14.

Finafloxacin overcomes Burkholderia pseudomallei efflux-mediated fluoroquinolone resistance.

Randall LB, Georgi E, Genzel GH, Schweizer HP.

J Antimicrob Chemother. 2017 Apr 1;72(4):1258-1260. doi: 10.1093/jac/dkw529. No abstract available.

15.

Thermoregulation of Biofilm Formation in Burkholderia pseudomallei Is Disrupted by Mutation of a Putative Diguanylate Cyclase.

Plumley BA, Martin KH, Borlee GI, Marlenee NL, Burtnick MN, Brett PJ, AuCoin DP, Bowen RA, Schweizer HP, Borlee BR.

J Bacteriol. 2017 Feb 14;199(5). pii: e00780-16. doi: 10.1128/JB.00780-16. Print 2017 Mar 1.

16.

Antibiotic resistance in Burkholderia species.

Rhodes KA, Schweizer HP.

Drug Resist Updat. 2016 Sep;28:82-90. doi: 10.1016/j.drup.2016.07.003. Epub 2016 Jul 30. Review.

17.

Versatile nourseothricin and streptomycin/spectinomycin resistance gene cassettes and their use in chromosome integration vectors.

Lehman SS, Mladinich KM, Boonyakanog A, Mima T, Karkhoff-Schweizer RR, Schweizer HP.

J Microbiol Methods. 2016 Oct;129:8-13. doi: 10.1016/j.mimet.2016.07.018. Epub 2016 Jul 22.

18.

Membrane-Bound PenA β-Lactamase of Burkholderia pseudomallei.

Randall LB, Dobos K, Papp-Wallace KM, Bonomo RA, Schweizer HP.

Antimicrob Agents Chemother. 2015 Dec 28;60(3):1509-14. doi: 10.1128/AAC.02444-15.

19.

Absence of Bacteria in the Temporal Arteries of Patients with Giant Cell Arteritis.

Koening CL, Peterson SG, Podnecky NL, Schweizer HP, Li DY, Katz BJ.

J Clin Rheumatol. 2016 Jan;22(1):43-4. doi: 10.1097/RHU.0000000000000344. No abstract available.

20.

Exposing a β-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-Lactamase.

Papp-Wallace KM, Becka SA, Taracila MA, Winkler ML, Gatta JA, Rholl DA, Schweizer HP, Bonomo RA.

Antimicrob Agents Chemother. 2015 Nov 23;60(2):777-88. doi: 10.1128/AAC.02073-15. Print 2016 Feb.

Supplemental Content

Loading ...
Support Center